Evidence map›Paper›PMID 20123894›Full record

ArticleGenes & development2010

Jarid2 and PRC2, partners in regulating gene expression.

Gang Li, Raphael Margueron, Manching Ku, Pierre Chambon, Bradley E Bernstein, Danny Reinberg

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 301 papers.

0numbers the graph read from it
0cells of the map it votes in
301citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

301 citing papers in PubMed, 495 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. EPOP and MTF2 activate PRC2 activity through DNA-sequence specificity.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

241 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Gang LiHoward Hughes Medical Institute, New York University Medical School, New York, New York 10016, USA.
Raphael Margueron
Manching Ku
Pierre Chambon
Bradley E Bernstein
Danny Reinberg
Howard Hughes Medical Institute · USCentre National de la Recherche Scientifique · FRHarvard University · USMassachusetts General Hospital · USNew York University · US

Funding

Initiation of Transcription of Protein Coding GenesR37GM037120 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI REINBERG, DANNY · 2004 to 2013
$4.5M
Transcription Regulation by NC2R01GM064844 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI REINBERG, DANNY · 2002 to 2014
$3.3M
Howard Hughes Medical InstituteNIGMS NIH HHS GM64844NIGMS NIH HHS R01 GM064844NIGMS NIH HHS R37 GM037120NIGMS NIH HHS R37GM37120
6 · The paper itself

Abstract

The Polycomb group proteins foster gene repression profiles required for proper development and unimpaired adulthood, and comprise the components of the Polycomb-Repressive Complex 2 (PRC2) including the histone H3 Lys 27 (H3K27) methyltransferase Ezh2. How mammalian PRC2 accesses chromatin is unclear. We found that Jarid2 associates with PRC2 and stimulates its enzymatic activity in vitro. Jarid2 contains a Jumonji C domain, but is devoid of detectable histone demethylase activity. Instead, its artificial recruitment to a promoter in vivo resulted in corecruitment of PRC2 with resultant increased levels of di- and trimethylation of H3K27 (H3K27me2/3). Jarid2 colocalizes with Ezh2 and MTF2, a homolog of Drosophila Pcl, at endogenous genes in embryonic stem (ES) cells. Jarid2 can bind DNA and its recruitment in ES cells is interdependent with that of PRC2, as Jarid2 knockdown reduced PRC2 at its target promoters, and ES cells devoid of the PRC2 component EED are deficient in Jarid2 promoter access. In addition to the well-documented defects in embryonic viability upon down-regulation of Jarid2, ES cell differentiation is impaired, as is Oct4 silencing.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsCell DifferentiationDrosophila ProteinsEmbryonic Stem CellsEnhancer of Zeste Homolog 2 ProteinHistone-Lysine N-MethyltransferaseMiceNerve Tissue ProteinsPolycomb-Group ProteinsPolycomb Repressive Complex 2Protein BindingRepressor ProteinsTranscription FactorsDrosophila ProteinsEnhancer of Zeste Homolog 2 ProteinEzh2 protein, mouseHistone-Lysine N-MethyltransferaseJarid2 protein, DrosophilaJarid2 protein, mouseMtf2 protein, mouseNerve Tissue ProteinsPolycomb-Group ProteinsPolycomb Repressive Complex 2Repressor ProteinsTranscription Factors

Identifiers

PMID20123894
PMCPMC2816736
OpenAlexW2154535417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.